1. Home
  2. VLRS vs TSHA Comparison

VLRS vs TSHA Comparison

Compare VLRS & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VLRS
  • TSHA
  • Stock Information
  • Founded
  • VLRS 2005
  • TSHA 2019
  • Country
  • VLRS Mexico
  • TSHA United States
  • Employees
  • VLRS N/A
  • TSHA N/A
  • Industry
  • VLRS Air Freight/Delivery Services
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • VLRS Consumer Discretionary
  • TSHA Health Care
  • Exchange
  • VLRS Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • VLRS 671.0M
  • TSHA 728.4M
  • IPO Year
  • VLRS N/A
  • TSHA 2020
  • Fundamental
  • Price
  • VLRS $6.07
  • TSHA $3.07
  • Analyst Decision
  • VLRS Buy
  • TSHA Strong Buy
  • Analyst Count
  • VLRS 6
  • TSHA 7
  • Target Price
  • VLRS $8.18
  • TSHA $8.71
  • AVG Volume (30 Days)
  • VLRS 433.6K
  • TSHA 3.5M
  • Earning Date
  • VLRS 10-21-2025
  • TSHA 11-12-2025
  • Dividend Yield
  • VLRS N/A
  • TSHA N/A
  • EPS Growth
  • VLRS N/A
  • TSHA N/A
  • EPS
  • VLRS N/A
  • TSHA N/A
  • Revenue
  • VLRS $3,019,191,000.00
  • TSHA $8,098,000.00
  • Revenue This Year
  • VLRS N/A
  • TSHA N/A
  • Revenue Next Year
  • VLRS $12.17
  • TSHA N/A
  • P/E Ratio
  • VLRS N/A
  • TSHA N/A
  • Revenue Growth
  • VLRS N/A
  • TSHA N/A
  • 52 Week Low
  • VLRS $3.49
  • TSHA $1.05
  • 52 Week High
  • VLRS $9.00
  • TSHA $3.40
  • Technical
  • Relative Strength Index (RSI)
  • VLRS 54.74
  • TSHA 53.47
  • Support Level
  • VLRS $5.88
  • TSHA $3.16
  • Resistance Level
  • VLRS $6.31
  • TSHA $2.99
  • Average True Range (ATR)
  • VLRS 0.17
  • TSHA 0.17
  • MACD
  • VLRS -0.03
  • TSHA 0.01
  • Stochastic Oscillator
  • VLRS 42.05
  • TSHA 46.34

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: